This document discusses the use of ambulatory spinal anaesthesia during the COVID-19 pandemic. It notes that spinal anaesthesia can reduce risks associated with general anaesthesia by avoiding airway manipulation and intubation. Short-acting local anaesthetics like prilocaine and 2-chloroprocaine allow spinal anaesthesia to be used for procedures less than 2 hours while avoiding complications from longer-acting drugs. The document provides guidance on selecting the appropriate local anaesthetic based on the specific procedure and on technical aspects of performing ambulatory spinal anaesthesia.